• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Research Brief on 2-Hydrazinyl-4-methoxy-6-methylpyrimidine (CAS: 36951-92-5) in Chemical Biology and Pharmaceutical Applications

2-Hydrazinyl-4-methoxy-6-methylpyrimidine (CAS: 36951-92-5) is a pyrimidine derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including potential drug candidates. Recent studies have explored its role in the development of novel therapeutic agents, particularly in the fields of oncology, infectious diseases, and metabolic disorders. The unique structural features of this compound, including the hydrazinyl and methoxy functional groups, make it a valuable scaffold for medicinal chemistry.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the use of 2-hydrazinyl-4-methoxy-6-methylpyrimidine as a building block for the synthesis of kinase inhibitors. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific tyrosine kinases implicated in cancer progression. The researchers employed a combination of computational modeling and in vitro assays to optimize the structure-activity relationship (SAR) of these derivatives, leading to the identification of several promising lead compounds with nanomolar potency.

Another recent application of 2-hydrazinyl-4-methoxy-6-methylpyrimidine was reported in the field of antimicrobial drug development. A 2022 study in Bioorganic & Medicinal Chemistry Letters highlighted its use as a precursor for the synthesis of novel antibacterial agents targeting multidrug-resistant pathogens. The study revealed that certain derivatives exhibited broad-spectrum activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli. The mechanism of action was attributed to the inhibition of bacterial DNA gyrase, a validated target for antibacterial therapy.

Beyond its direct therapeutic applications, 2-hydrazinyl-4-methoxy-6-methylpyrimidine has also been utilized as a versatile reagent in chemical biology. A 2023 Nature Communications paper described its use in the development of activity-based probes for studying enzyme function in live cells. The hydrazinyl group was shown to selectively react with carbonyl-containing metabolites, enabling the visualization of metabolic pathways in real-time. This approach provides a powerful tool for understanding disease mechanisms and identifying new drug targets.

The synthetic accessibility of 2-hydrazinyl-4-methoxy-6-methylpyrimidine has also been a focus of recent research. A 2021 Organic Process Research & Development publication detailed an improved, scalable synthesis route for this compound, addressing previous challenges related to yield and purity. The optimized protocol employs greener chemistry principles, reducing the use of hazardous solvents and improving overall process efficiency. This advancement is particularly relevant for industrial-scale production of pharmaceutical intermediates.

Looking forward, the potential applications of 2-hydrazinyl-4-methoxy-6-methylpyrimidine continue to expand. Current research directions include its incorporation into PROTAC (proteolysis-targeting chimera) molecules for targeted protein degradation, as well as its use in the development of covalent inhibitors for challenging drug targets. The compound's versatility and proven biological activity make it a valuable asset in the medicinal chemist's toolbox, with promising prospects for future drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)